Eli Lilly opens its $1B drug discovery models to biotechs
Eli Lilly just launched TuneLab, an AI platform giving biotech firms access to drug discovery models trained on over $1B worth of proprietary research data. The setup uses federated learning so startups can leverage Lilly's predictive chemistry models without exposing their own intellectual property.